The Spanish Competition Authority fines a contraceptive products company €39M for alleged abuse of patent rights (Merck Sharp)

KEYWORDS
Reference

Spanish Competition Authority, Merck Sharp & Dohme, Press release, 25 October 2022

This matter revolves around the disputed expiration of the patent behind Nuvaring, a vaginal ring anti-conceptive product. When Insud Pharma, the complainant in the case, entered the market using an alternative product which Merck considered

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Callol, Coca & Asociados (Madrid)
    Spain 169 contributions 44488 visits

Quotation

Pedro Callol, The Spanish Competition Authority fines a contraceptive products company €39M for alleged abuse of patent rights (Merck Sharp), 25 October 2022, e-Competitions October 2022, Art. N° 109765

Visites 61

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues